Why do some species live for only weeks while others survive for centuries? Researchers at the Leibniz Institute on ...

The recently released 6.3 version of Apple’s Swift programming language features the official release of the Swift SDK for Android, which means that developers can now use Swift to write Android ...

These great optics will get you a good view of the “blood moon,” but you can also use them long after the event to level up your stargazing. When you purchase through links on our site, we may earn an ...

Texas’ medical marijuana program is expanding, with new laws now in effect that increase access for patients across the state, including in North Texas. While much of the debate in 2025 centered on ...

The H-2A program continues to grow, with 13,358 more positions certified in fiscal year 2025 (October 2024-September 2025) than fiscal year 2024. This marks the first year in program history that over ...

ESA's Proba-3 mission, made up of twin spacecraft capable of aligning to create artificial eclipses, has captured "rare" footage of three solar prominences erupting from the sun's mysteriously hot ...

AUSTIN, Texas — Nine new businesses have been granted conditional cannabis dispensary licenses as Texas expands its Compassionate Use Program for medical marijuana. The new companies include Central ...

When running a Java program in Eclipse IDE that uses Scanner.nextLine() for user input, the console fails to reposition the input cursor correctly after an exception or invalid input. Even though the ...

ECLIPSE registrational program now fully underway, following enrollment of the first patient in ECLIPSE 3 ECLIPSE 3 is designed to compare the combination of tobevibart and elebsiran to bulevirtide in ...

First patient enrolled in ECLIPSE 2 Phase 3 clinical trial evaluating the switch to the combination of tobevibart and elebsiran in patients not achieving undetectable hepatitis delta virus RNA despite ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in the ECLIPSE 2 Phase 3 clinical trial, which is designed to compare the ...